{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:44Z","timestamp":1787020784881,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["CFH, shoufa-2022-1G-1131"],"award-info":[{"award-number":["CFH, shoufa-2022-1G-1131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Under the pressure of non-pharmaceutical interventions (NPIs) targeting severe acute respiratory syndrome coronavirus 2, the prevalence of human adenovirus (HAdV) was monitored before and after NPIs launched on Jan 24, 2020 in pediatric patients in Beijing, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Respiratory samples collected from children hospitalized with acute respiratory infections from Jan 2015 to Dec 2021 were screened by direct immunofluorescence test or capillary electrophoresis-based multiplex PCR assay. The hexon, penton base, and fiber genes were amplified from HAdV positive specimens, then sequenced. For HAdV typing, phylogenetic trees were built by MEGA X. Then clinical data of HAdV positive cases were collected. All data were evaluated using SPSS Statistics 22.0 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 16,097 children were enrolled and 466 (2.89%, 466\/16,097) were HAdV-positive. The positive rates of HAdV varied, ranging from 4.39% (151\/3,438) in 2018 to1.25% (26\/2,081) in 2021, dropped from 3.19% (428\/13,408) to 1.41% (38\/2,689) from before to after NPIs launched (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). There were 350 cases typed into nine types of species B, C, or E and 34 recorded as undetermined. Among them, HAdV-B3 (51.56%, 198\/384) was the most prevalent types from 2015 to 2017, and HAdV-B7 (29.17%, 112\/384) co-circulated with HAdV-B3 from 2018 to 2019. After NPIs launched, HAdV-B3 and B7 decreased sharply with HAdV-B7 undetected in 2021, while HAdV-C1 became the dominant one and the undetermined were more.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The endemic pattern of HAdV changed in Beijing because of the NPIs launched for COVID-19. Especially, the dominant types changed from HAdV-B to HAdV-C.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-023-01962-y","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:04:47Z","timestamp":1673251487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The changed endemic pattern of human adenovirus from species B to C among pediatric patients under the pressure of non-pharmaceutical interventions against COVID-19 in Beijing, China"],"prefix":"10.1186","volume":"20","author":[{"given":"Fangming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"10243","key":"1962_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(20)31278-2","volume":"396","author":"Z Li","year":"2020","unstructured":"Li Z, Chen Q, Feng L, Rodewald L, Xia Y, Yu H, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020;396(10243):63\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(20)31278-2.","journal-title":"Lancet"},{"issue":"12","key":"1962_CR2","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1111\/ajt.16381","volume":"20","author":"SJ Olsen","year":"2020","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transpl. 2020;20(12):3681\u20135. https:\/\/doi.org\/10.1111\/ajt.16381.","journal-title":"Am J Transpl"},{"issue":"4","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/idr14040059","volume":"14","author":"I Garg","year":"2022","unstructured":"Garg I, Shekhar R, Sheikh AB, Pal S. Impact of COVID-19 on the changing patterns of respiratory syncytial virus infections. Infect Dis Rep. 2022;14(4):558\u201368. https:\/\/doi.org\/10.3390\/idr14040059.","journal-title":"Infect Dis Rep"},{"issue":"6","key":"1962_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s12519-021-00477-2","volume":"17","author":"RX Zhang","year":"2021","unstructured":"Zhang RX, Chen DM, Qian Y, Sun Y, Zhu RN, Wang F, et al. Surges of hospital-based rhinovirus infection during the 2020 coronavirus disease-19 (COVID-19) pandemic in Beijing, China. World J Pediatr. 2021;17(6):590\u20136. https:\/\/doi.org\/10.1007\/s12519-021-00477-2.","journal-title":"World J Pediatr"},{"issue":"2","key":"1962_CR5","first-page":"75","volume":"103","author":"F Touzard-Romo","year":"2013","unstructured":"Touzard-Romo F, Tape C, Lonks JR. Co-infection with SARS-CoV-2 and human metapneumovirus. R I Med J. 2013;103(2):75\u20136.","journal-title":"R I Med J"},{"issue":"1","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","volume":"12","author":"QS Huang","year":"2021","unstructured":"Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1001. https:\/\/doi.org\/10.1038\/s41467-021-21157-9.","journal-title":"Nat Commun"},{"issue":"Pt 1","key":"1962_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.003087-0","volume":"90","author":"WC Russell","year":"2009","unstructured":"Russell WC. Adenoviruses: update on structure and function. J Gen Virol. 2009;90(Pt 1):1\u201320. https:\/\/doi.org\/10.1099\/vir.0.003087-0.","journal-title":"J Gen Virol"},{"issue":"6","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/14760584.2019.1588113","volume":"18","author":"FJD Mennechet","year":"2019","unstructured":"Mennechet FJD, Paris O, Ouoba AR, Salazar Arenas S, Sirima SB, Takoudjou Dzomo GR, et al. A review of 65 years of human adenovirus seroprevalence. Expert Rev Vaccines. 2019;18(6):597\u2013613. https:\/\/doi.org\/10.1080\/14760584.2019.1588113.","journal-title":"Expert Rev Vaccines"},{"key":"1962_CR9","unstructured":"HAdV Working Group, (2022). http:\/\/hadvwg.gmu.edu. Accessed on 10 November 2022."},{"issue":"11","key":"1962_CR10","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1128\/JVI.00354-11","volume":"85","author":"D Seto","year":"2011","unstructured":"Seto D, Chodosh J, Brister JR, Jones MS. Members of the Adenovirus Research Community. Using the whole-genome sequence to characterize and name human adenoviruses. J Virol. 2011;85(11):5701\u20132. https:\/\/doi.org\/10.1128\/JVI.00354-11.","journal-title":"J Virol"},{"issue":"4","key":"1962_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1055\/s-0036-1584923","volume":"37","author":"JR Lynch","year":"2016","unstructured":"Lynch JR, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med. 2016;37(4):586\u2013602. https:\/\/doi.org\/10.1055\/s-0036-1584923.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"1962_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.virs.2022.01.010","volume":"37","author":"W Liu","year":"2022","unstructured":"Liu W, Qiu S, Zhang L, Wu H, Tian X, Li X, et al. Analysis of severe human adenovirus infection outbreak in Guangdong Province, southern China in 2019. Virol Sin. 2022;37(3):331\u201340. https:\/\/doi.org\/10.1016\/j.virs.2022.01.010.","journal-title":"Virol Sin"},{"issue":"3","key":"1962_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12250-020-00299-y","volume":"36","author":"C Yang","year":"2021","unstructured":"Yang C, Zhu C, Qian Y, Deng J, Zhang B, Zhu R, et al. Application of human adenovirus genotyping by phylogenetic analysis in an outbreak to identify nosocomial infection. Virol Sin. 2021;36(3):393\u2013401. https:\/\/doi.org\/10.1007\/s12250-020-00299-y.","journal-title":"Virol Sin"},{"key":"1962_CR14","unstructured":"Centers for Disease Control and Prevention Adenoviruses | Surveillance Data for National Adenovirus Type Reporting System (NATRS). https:\/\/www.cdc.gov\/adenovirus\/reporting-surveillance\/natrs\/surveillance-data.html. Accessed 10 Nov 2022."},{"issue":"4","key":"1962_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/infdis\/jiz489","volume":"221","author":"KK Coleman","year":"2020","unstructured":"Coleman KK, Wong CC, Jayakumar J, Nguyen TT, Wong AWL, Yadana S, et al. Adenoviral infections in Singapore: should new antiviral therapies and vaccines be adopted? J Infect Dis. 2020;221(4):566\u201377. https:\/\/doi.org\/10.1093\/infdis\/jiz489.","journal-title":"J Infect Dis"},{"issue":"1","key":"1962_CR16","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1093\/cid\/ciab942","volume":"75","author":"ZJ Li","year":"2022","unstructured":"Li ZJ, Yu LJ, Zhang HY, Shan CX, Lu QB, Zhang XA, et al. Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. 2022;75(1):e1054\u201362. https:\/\/doi.org\/10.1093\/cid\/ciab942.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1962_CR17","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1038\/s41467-021-25120-6","volume":"12","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Zhang HY, Ren LL, Lu QB, Ren X, Zhang CH, et al. Etiological and epidemiological features of acute respiratory infections in China. Nat Commun. 2021;12(1):5026. https:\/\/doi.org\/10.1038\/s41467-021-25120-6.","journal-title":"Nat Commun"},{"key":"1962_CR18","doi-asserted-by":"publisher","first-page":"911694","DOI":"10.3389\/fmicb.2022.911694","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Zhang J, Lan W, Quan L, Ou J, Zhao W, et al. Molecular typing and rapid identification of human adenoviruses associated with respiratory diseases using universal PCR and sequencing primers for the three major capsid genes: penton base, hexon, and fiber. Front Microbiol. 2022;13:911694. https:\/\/doi.org\/10.3389\/fmicb.2022.911694.","journal-title":"Front Microbiol."},{"issue":"10","key":"1962_CR19","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731\u20139. https:\/\/doi.org\/10.1093\/molbev\/msr121.","journal-title":"Mol Biol Evol"},{"issue":"19","key":"1962_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2020.6130","volume":"323","author":"A Pan","year":"2020","unstructured":"Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan. China JAMA. 2020;323(19):1915\u201323. https:\/\/doi.org\/10.1001\/jama.2020.6130.","journal-title":"China JAMA"},{"issue":"3","key":"1962_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1128\/CMR.00116-13","volume":"27","author":"T Lion","year":"2014","unstructured":"Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27(3):441\u201362. https:\/\/doi.org\/10.1128\/CMR.00116-13.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"1962_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12519-022-00590-w","volume":"18","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lin T, Wang CB, Liang WL, Lian GW, Zanin M, et al. Human adenovirus (HAdV) infection in children with acute respiratory tract infections in Guangzhou, China, 2010\u20132021: a molecular epidemiology study. World J Pediatr. 2022;18(8):545\u201352. https:\/\/doi.org\/10.1007\/s12519-022-00590-w.","journal-title":"World J Pediatr"},{"issue":"29","key":"1962_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm7029a1","volume":"70","author":"SJ Olsen","year":"2021","unstructured":"Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020\u20132021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7029a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1962_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9338","author":"JM Brauner","year":"2021","unstructured":"Brauner JM, Mindermann S, Sharma M, Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gaven\u010diak T, et al. Inferring the effectiveness of government interventions against COVID-19. Science. 2021. https:\/\/doi.org\/10.1126\/science.abd9338.","journal-title":"Science"},{"issue":"5","key":"1962_CR25","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2468-2667(20)30090-6","volume":"5","author":"BJ Cowling","year":"2020","unstructured":"Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279\u201388. https:\/\/doi.org\/10.1016\/S2468-2667(20)30090-6.","journal-title":"Lancet Public Health"},{"issue":"4","key":"1962_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jinf.2022.07.015","volume":"85","author":"M Li","year":"2022","unstructured":"Li M, Luo Q, Gong C, Li AH, Dong M, Zhang H, et al. Prospective surveillance of human adenovirus in acute respiratory infections reveals epidemiological features and the disappearance of species B during the COVID-19 pandemic in Beijing, China. J Infect. 2022;85(4):436\u201380. https:\/\/doi.org\/10.1016\/j.jinf.2022.07.015.","journal-title":"J Infect"},{"issue":"6","key":"1962_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3201\/eid2206.151898","volume":"22","author":"MK Scott","year":"2016","unstructured":"Scott MK, Chommanard C, Lu X, Appelgate D, Grenz L, Schneider E, et al. Human adenovirus associated with severe respiratory infection, Oregon, USA, 2013\u20132014. Emerg Infect Dis. 2016;22(6):1044\u201351. https:\/\/doi.org\/10.3201\/eid2206.151898.","journal-title":"Emerg Infect Dis"},{"key":"1962_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/v11121131","author":"K Takahashi","year":"2019","unstructured":"Takahashi K, Gonzalez G, Kobayashi M, Hanaoka N, Carr MJ, Konagaya M, et al. Pediatric infections by human mastadenovirus C Types 2, 89, and a recombinant type detected in Japan between 2011 and 2018. Viruses. 2019. https:\/\/doi.org\/10.3390\/v11121131.","journal-title":"Viruses"},{"issue":"2","key":"1962_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmi.2016.11.004","volume":"23","author":"MR Lin","year":"2017","unstructured":"Lin MR, Yang SL, Gong YN, Kuo CC, Chiu CH, Chen CJ, et al. Clinical and molecular features of adenovirus type 2, 3, and 7 infections in children in an outbreak in Taiwan, 2011. Clin Microbiol Infect. 2017;23(2):110\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2016.11.004.","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"1962_CR30","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1128\/jvi.76.21.10608-10616.2002","volume":"76","author":"CT Garnett","year":"2002","unstructured":"Garnett CT, Erdman D, Xu W, Gooding LR. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol. 2002;76(21):10608\u201316. https:\/\/doi.org\/10.1128\/jvi.76.21.10608-10616.2002.","journal-title":"J Virol"},{"issue":"8","key":"1962_CR31","doi-asserted-by":"publisher","first-page":"e1003974","DOI":"10.1371\/journal.pmed.1003974","volume":"19","author":"RG Nijman","year":"2022","unstructured":"Nijman RG, Honeyford K, Farrugia R, Rose K, Bognar Z, Buonsenso D, et al. Presentations of children to emergency departments across Europe and the COVID-19 pandemic: a multinational observational study. PLoS Med. 2022;19(8):e1003974. https:\/\/doi.org\/10.1371\/journal.pmed.1003974.","journal-title":"PLoS Med"},{"key":"1962_CR32","doi-asserted-by":"publisher","first-page":"938372","DOI":"10.3389\/fmicb.2022.938372","volume":"13","author":"R Jia","year":"2022","unstructured":"Jia R, Lu L, Su L, Lin Z, Gao D, Lv H, et al. Resurgence of respiratory syncytial virus infection during COVID-19 pandemic among children in Shanghai, China. Front Microbiol. 2022;13:938372. https:\/\/doi.org\/10.3389\/fmicb.2022.938372.","journal-title":"Front Microbiol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-01962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-01962-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-01962-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T10:26:38Z","timestamp":1673605598000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-01962-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-01962-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original study was approved by the Ethics Committee of the Capital Institute of Pediatrics (Approval number: SHERLLM2022027) and was a retrospective and prospective study. The ethical committee had voted that written informed consents were not required for HAdV positive specimens collected retrospectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}